BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14608901)

  • 21. Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens.
    Trpkov K; Bartczak-McKay J; Yilmaz A
    Am J Clin Pathol; 2009 Aug; 132(2):211-20; quiz 307. PubMed ID: 19605815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
    Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
    Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens.
    Helpap B
    Virchows Arch; 2006 Apr; 448(4):480-4. PubMed ID: 16506014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal cell hyperplasia (BCH) versus high grade prostatic intraepithelial neoplasia (HGPIN) in tiny prostatic needle biopsies: Unusual diagnostic dilemma.
    Yassin Fel-Z; Muhammad EM; Zaki M; Saleem MD; Mohammed RA
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):15-22. PubMed ID: 24565678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma].
    Chen GY; Liu LN; Zhou XG; Zhang CH; Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):419-23. PubMed ID: 15498210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer].
    Molinié V; Hervé JM; Lebret T; Lugagne-Delpon PM; Saporta F; Yonneau L; Botto H; Baglin AC
    Ann Pathol; 2004 Feb; 24(1):6-16. PubMed ID: 15192532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
    Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
    Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate adenocarcinoma detected after high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation.
    López JI
    BJU Int; 2007 Dec; 100(6):1272-6. PubMed ID: 17850386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer.
    Schowinsky JT; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):866-70. PubMed ID: 16819329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens.
    Singh V; Manu V; Malik A; Dutta V; Mani NS; Patrikar S
    J Cancer Res Ther; 2014; 10(3):686-92. PubMed ID: 25313761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P504S: a new molecular marker for the detection of prostate carcinoma.
    Jiang Z; Woda BA; Rock KL; Xu Y; Savas L; Khan A; Pihan G; Cai F; Babcook JS; Rathanaswami P; Reed SG; Xu J; Fanger GR
    Am J Surg Pathol; 2001 Nov; 25(11):1397-404. PubMed ID: 11684956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies.
    Evans AJ
    J Clin Pathol; 2003 Dec; 56(12):892-7. PubMed ID: 14645345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of p63/P504S monoclonal antibody cocktail in immunohistochemical staining of prostate tissue.
    Tacha DE; Miller RT
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):75-8. PubMed ID: 15163024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.
    Jiang Z; Wu CL; Woda BA; Dresser K; Xu J; Fanger GR; Yang XJ
    Am J Surg Pathol; 2002 Sep; 26(9):1169-74. PubMed ID: 12218573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
    Jiang Z; Li C; Fischer A; Dresser K; Woda BA
    Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.